Tag Archive for: fenebrutinib

Innerstream - wikimedia.org
Multiple sclerosis

Roche with good interim clinical results

Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression after one year in patients with relapsing multiple sclerosis

Read more
Multiple sclerosis

Roche’s meets endpoints in relapsing multiple sclerosis

Roche’s bruton’s tyrosine kinas blocker fenebrutinib has met all endpoints in proof-of-concept study with patients suffering from relapsing-remitting multiple sclerosis.

Read more